Center for State, Tribal, Local, and Territorial Support (CSTLTS), CDC/ATSDR Tribal Consultation Session, 35298-35299 [2021-14205]

Download as PDF 35298 Federal Register / Vol. 86, No. 125 / Friday, July 2, 2021 / Notices partners across state health departments and collaborating divisions within CDC. The information collection and reporting requirements have been carefully designed to align with, and support the specific goals and outcomes outlined in the Core SIPP cooperative agreement. The overarching goal of Core SIPP is to strengthen the awardee’s injury prevention programs and policies and demonstrate impact in the reduction of injury-related morbidity and mortality. Although the data are limited to the 23 recipients of the Core SIPP NOFO, the results can be generalizable and inform injury prevention work. Moreover, it is asserted that the results of the data collection are vital to ensuring the Core SIPPs efficient management. Results will not only allow NCIPC staff to provide data-driven technical assistance to recipients, but also to assess patterns across other NCIPC injury prevention programs such as, Prescription Drug Overdose Prevention for States and the Injury Control Research Centers. In addition, the data collection will inform the continuous quality improvement process and allow NCIPC staff to make mid-course corrections and describe the impact on health outcomes. prevention and control strategies implemented by recipients through the development of journal articles, tools, templates, and other injury prevention resources/products. Program recipients will use the information collected to manage and coordinate their activities and to improve their efforts to prevent and control injuries. The Partners’ Portal allows recipients to fulfill their annual reporting obligations efficiently by employing user-friendly, easily accessible web-based instruments to collect necessary information for both progress reports and continuation applications including work plans. This approach enables recipients to save pertinent information from one reporting period to the next and reduces the administrative burden on the annual continuation application and the performance monitoring process. Awardee program staff are able to review the completeness of data needed to generate required reports, enter basic summary data for reports annually, and finalize and save required reports for upload into other reporting systems as required. The information collection procedures will also allow NCIPC to respond to inquiries from the HHS, the White House, Congress and other stakeholders about program activities and their impact; as well as, work towards CDCs overarching mission to protect America from health, safety and security threats, both foreign and in the U.S. NCIPC will use the information collected in the Partners’ Portal to perform program activities to accomplish the following objectives: • Monitor each awardee’s progress and identify facilitators and barriers to program implementation and achievement of outcomes. Monitoring allows NCIPC to determine whether an awardee is meeting performance goals, to inform awardee continuous quality improvements, and to inform the type of intensity of CDC-provided technical assistance to support attainment of their performance measures. • Identify trends in injury surveillance data to inform state foci for prevention and intervention strategies as well as the production of relevant reports, journal articles, and resources for state health departments. • Identify, translate, and disseminate information about successful injury ESTIMATED ANNUALIZED BURDEN HOURS Number of responses per respondent Average burden per response (in hours) Total burden (in hours) Form name Core SIPP Program Recipients ........ Annual Progress Report ................... 23 1 11 253 Total ........................................... ........................................................... ........................ ........................ ........................ 253 Jeffrey M. Zirger, Lead, Information Collection Review Office, Office of Scientific Integrity, Office of Science, Centers for Disease Control and Prevention. (ATSDR), Department of Health and Human Services (HHS). ACTION: Notice of meeting. [FR Doc. 2021–14224 Filed 7–1–21; 8:45 am] SUMMARY: BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Agency for Toxic Substances and Disease Registry lotter on DSK11XQN23PROD with NOTICES1 Number of respondents Type of respondents Center for State, Tribal, Local, and Territorial Support (CSTLTS), CDC/ ATSDR Tribal Consultation Session Centers for Disease Control and Prevention (CDC)/Agency for Toxic Substances and Disease Registry AGENCY: VerDate Sep<11>2014 18:50 Jul 01, 2021 Jkt 253001 The Centers for Disease Control and Prevention (CDC)/Agency for Toxic Substances and Disease Registry (ATSDR), announces the 2021 CDC/ATSDR Tribal Consultation Session. CDC/ATSDR will host American Indian and Alaska Native (AI/ AN) Federally Recognized Tribes for the virtual tribal consultation session. The proceedings will be open to the public. DATES: The tribal consultation will be held on August 5, 2021, from 3:15 p.m. to 5:00 p.m., EDT. Written tribal testimony is due by 5:00 p.m., EDT, on September 7, 2021. ADDRESSES: Zoom Virtual Tribal Consultation. To register, see CDC web page https://cdc.zoomgov.com/meeting/ register/vJIsfu-gqDgsGD1rTre7HPjbXy IF3v5jSp4. All elected tribal officials are PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 encouraged to submit written tribal testimony to the contact person and mailing address listed below or by email at Tribalsupport@cdc.gov. FOR FURTHER INFORMATION CONTACT: Captain Karen Hearod, MSW, LCSW, Director, Office of Tribal Affairs and Strategic Alliances, Center for State, Tribal, Local, and Territorial Support, CDC, 1600 Clifton Road NE, Mailstop V18–4, Atlanta, GA 30329–4027; Telephone: (404) 498–0300; Email: Tribalsupport@cdc.gov. SUPPLEMENTARY INFORMATION: This meeting is being held in accordance with Presidential Executive Order No. 13175, November 6, 2000, and the Presidential Memorandum of November 5, 2009, and September 23, 2004, Consultation and Coordination with Indian Tribal Governments. Purpose: The purpose of the consultation meeting is to advance CDC/ ATSDR support for and collaboration E:\FR\FM\02JYN1.SGM 02JYN1 lotter on DSK11XQN23PROD with NOTICES1 Federal Register / Vol. 86, No. 125 / Friday, July 2, 2021 / Notices with AI/AN tribal nations and to improve the health of AI/AN tribal nations by pursuing goals that include assisting in eliminating the health disparities faced by AI/AN tribal nations; ensuring that access to critical health and human services and public health services is maximized to advance or enhance the social, physical, and economic status of AI/AN people; and promoting health equity for all Indian people and communities. To advance these goals, CDC/ATSDR conducts government-to-government consultations with elected tribal officials or their authorized representatives. Consultation is an enhanced form of communication that emphasizes trust, respect, and shared responsibility. It is an open and free exchange of information and opinion among parties that leads to mutual understanding. Matters To Be Considered: CDC/ ATSDR is hosting this meeting to hold a consultation with federally recognized tribal nations to receive input and guidance on improving the current CDC/ATSDR Tribal Consultation Policy. CDC/ATSDR is seeking feedback on how the agency can improve its policies and practices to better engage with Indian Country through meaningful consultation. This feedback will be used to edit the current CDC’s Consultation Policy. The Tribal consultation session will provide opportunities for elected AI/AN tribal officials to speak openly about the public health issues affecting their tribal nations. This consultation session is virtual and open to the public. Elected tribal officials can find guidance to assist in developing tribal testimony for CDC/ATSDR at https://www.cdc.gov/ tribal/documents/consultation/TribalTestimony-Guidance.pdf. Please submit tribal testimony on official tribal letterhead. Based on the number of elected tribal officials giving testimony and the time available, it may be necessary to limit the time for each presenter. We will adjourn tribal consultation meetings early if all attendees who requested to provide oral testimony in advance of and during the consultation have delivered their comments. Agenda items are subject to change as priorities dictate. Additional information about CDC/ ATSDR’s Tribal Consultation Policy can be found at https://www.cdc.gov/tribal/ consultation-support/tribalconsultation/policy.html. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal VerDate Sep<11>2014 17:12 Jul 01, 2021 Jkt 253001 Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2021–14205 Filed 7–1–21; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [Docket No. CDC–2021–0034] Advisory Committee on Immunization Practices (ACIP); Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Advisory Committee on Immunization Practices (ACIP); June 23, 2021, from 10:00 a.m. to 5:00 p.m., EDT (times subject to change); June 24, 2021, from 10:30 a.m. to 5:10 p.m., EDT (times subject to change); and June 25, 2021, from 10:00 a.m. to 12:20 p.m., EDT (times subject to change), in the amended FRN. The virtual meeting was published in the Federal Register on Wednesday, June 23, 2021, Volume 86, Number 118, pages 32933–32934. The virtual meeting is being amended to update the meeting times on June 23– 25, 2021 (times subject to change) and matters to be considered and should read as follows: SUMMARY: In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC), announces the following meeting of the Advisory Committee on Immunization Practices (ACIP). This meeting is open to the public. Time will be available for public comment. The meeting will be webcast live via the World Wide Web; for more information on ACIP please visit the ACIP website: http://www.cdc.gov/ vaccines/acip/index.html. DATES: The meeting will be held on June 23, 2021, from 11:00 a.m. to 4:00 p.m., EDT (times subject to change); June 24, 2021, from 10:00 a.m. to 5:15 p.m., EDT (times subject to change); and June 25, 2021, from 10:00 a.m. to 1:00 p.m., EDT (times subject to change). Written comments must be received on or before June 25, 2021. A notice of this ACIP meeting has also been posted on CDC’s ACIP website at: http://www.cdc.gov/vaccines/acip/ PO 00000 Frm 00041 Fmt 4703 Sfmt 9990 35299 index.html. In addition, CDC has sent notice of this ACIP meeting by email to those who subscribe to receive email updates about ACIP. FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, ACIP Committee Management Specialist, Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, 1600 Clifton Road NE, MS–H24–8, Atlanta, GA 30329– 4027; Telephone: 404–639–8367; Email: ACIP@cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: The committee is charged with advising the Director, CDC, on the use of immunizing agents. In addition, under 42 U.S.C. 1396s, the committee is mandated to establish and periodically review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the Vaccines for Children (VFC) program, along with schedules regarding dosing interval, dosage, and contraindications to administration of vaccines. Further, under provisions of the Affordable Care Act, section 2713 of the Public Health Service Act, immunization recommendations of the ACIP that have been approved by the Director of the Centers for Disease Control and Prevention and appear on CDC immunization schedules must be covered by applicable health plans. Matters To Be Considered: The agenda will include discussions on COVID–19, dengue vaccine, herpes zoster vaccines, influenza vaccines, pneumococcal vaccine, and rabies vaccine. Recommendation votes on dengue vaccine, influenza vaccines and rabies vaccine are scheduled. Vaccines for Children (VFC) votes on dengue vaccine and influenza vaccines are scheduled. Agenda items are subject to change as priorities dictate. For more information on the meeting agenda visit https:// www.cdc.gov/vaccines/acip/meetings/ meetings-info.html. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2021–14203 Filed 7–1–21; 8:45 am] BILLING CODE 4163–18–P E:\FR\FM\02JYN1.SGM 02JYN1

Agencies

[Federal Register Volume 86, Number 125 (Friday, July 2, 2021)]
[Notices]
[Pages 35298-35299]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-14205]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

Agency for Toxic Substances and Disease Registry


Center for State, Tribal, Local, and Territorial Support 
(CSTLTS), CDC/ATSDR Tribal Consultation Session

AGENCY: Centers for Disease Control and Prevention (CDC)/Agency for 
Toxic Substances and Disease Registry (ATSDR), Department of Health and 
Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC)/Agency 
for Toxic Substances and Disease Registry (ATSDR), announces the 2021 
CDC/ATSDR Tribal Consultation Session. CDC/ATSDR will host American 
Indian and Alaska Native (AI/AN) Federally Recognized Tribes for the 
virtual tribal consultation session. The proceedings will be open to 
the public.

DATES: The tribal consultation will be held on August 5, 2021, from 
3:15 p.m. to 5:00 p.m., EDT. Written tribal testimony is due by 5:00 
p.m., EDT, on September 7, 2021.

ADDRESSES: Zoom Virtual Tribal Consultation. To register, see CDC web 
page https://cdc.zoomgov.com/meeting/register/vJIsfu-gqDgsGD1rTre7HPjbXyIF3v5jSp4. All elected tribal officials are 
encouraged to submit written tribal testimony to the contact person and 
mailing address listed below or by email at [email protected].

FOR FURTHER INFORMATION CONTACT: Captain Karen Hearod, MSW, LCSW, 
Director, Office of Tribal Affairs and Strategic Alliances, Center for 
State, Tribal, Local, and Territorial Support, CDC, 1600 Clifton Road 
NE, Mailstop V18-4, Atlanta, GA 30329-4027; Telephone: (404) 498-0300; 
Email: [email protected].

SUPPLEMENTARY INFORMATION: This meeting is being held in accordance 
with Presidential Executive Order No. 13175, November 6, 2000, and the 
Presidential Memorandum of November 5, 2009, and September 23, 2004, 
Consultation and Coordination with Indian Tribal Governments.
    Purpose: The purpose of the consultation meeting is to advance CDC/
ATSDR support for and collaboration

[[Page 35299]]

with AI/AN tribal nations and to improve the health of AI/AN tribal 
nations by pursuing goals that include assisting in eliminating the 
health disparities faced by AI/AN tribal nations; ensuring that access 
to critical health and human services and public health services is 
maximized to advance or enhance the social, physical, and economic 
status of AI/AN people; and promoting health equity for all Indian 
people and communities. To advance these goals, CDC/ATSDR conducts 
government-to-government consultations with elected tribal officials or 
their authorized representatives. Consultation is an enhanced form of 
communication that emphasizes trust, respect, and shared 
responsibility. It is an open and free exchange of information and 
opinion among parties that leads to mutual understanding.
    Matters To Be Considered: CDC/ATSDR is hosting this meeting to hold 
a consultation with federally recognized tribal nations to receive 
input and guidance on improving the current CDC/ATSDR Tribal 
Consultation Policy. CDC/ATSDR is seeking feedback on how the agency 
can improve its policies and practices to better engage with Indian 
Country through meaningful consultation. This feedback will be used to 
edit the current CDC's Consultation Policy. The Tribal consultation 
session will provide opportunities for elected AI/AN tribal officials 
to speak openly about the public health issues affecting their tribal 
nations. This consultation session is virtual and open to the public. 
Elected tribal officials can find guidance to assist in developing 
tribal testimony for CDC/ATSDR at https://www.cdc.gov/tribal/documents/consultation/Tribal-Testimony-Guidance.pdf. Please submit tribal 
testimony on official tribal letterhead.
    Based on the number of elected tribal officials giving testimony 
and the time available, it may be necessary to limit the time for each 
presenter. We will adjourn tribal consultation meetings early if all 
attendees who requested to provide oral testimony in advance of and 
during the consultation have delivered their comments. Agenda items are 
subject to change as priorities dictate.
    Additional information about CDC/ATSDR's Tribal Consultation Policy 
can be found at https://www.cdc.gov/tribal/consultation-support/tribal-consultation/policy.html.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-14205 Filed 7-1-21; 8:45 am]
BILLING CODE 4163-18-P